• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗唾液酸神经节苷脂/粒细胞巨噬细胞集落刺激因子融合蛋白促进中性粒细胞抗体依赖性细胞毒性作用,并且增强效应细胞黏附及嗜天青颗粒胞吐作用依赖于FcγRII(CD32)和Mac-1(CD11b/CD18)。

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.

作者信息

Metelitsa Leonid S, Gillies Stephen D, Super Michael, Shimada Hiroyuki, Reynolds C Patrick, Seeger Robert C

机构信息

Department of Pediatrics, Division of Hematology-Oncology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles 90027, USA.

出版信息

Blood. 2002 Jun 1;99(11):4166-73. doi: 10.1182/blood.v99.11.4166.

DOI:10.1182/blood.v99.11.4166
PMID:12010822
Abstract

Polymorphonuclear leukocytes (PMNs) mediate antibody-dependent cellular cytotoxicity (ADCC), which is increased by the addition of granulocyte-macrophage colony-stimulating factor (GM-CSF). We sought to determine whether PMN ADCC also would be increased by the addition of an antibody/GM-CSF fusion protein and whether this would be associated with the up-regulation and activation of Mac-1 (CD11b/CD18) and with azurophil granule exocytosis. ADCC against LA-N-1 human neuroblastoma cells was evaluated with 4-hour calcein acetoxymethyl ester (calcein-AM) microcytotoxicity assay, electron microscopy, and multi-parameter flow cytometry. With the calcein-AM assay, LA-N-1 cell survival was 10%, 55%, and 75% when PMN ADCC was mediated by the antidisialoganglioside (anti-GD2) immunocytokine hu14.18/GM-CSF, by monoclonal antibody (mAb) hu14.18 mixed with GM-CSF, and by hu14.18 alone. Function-blocking mAbs demonstrated that FcgammaRII and FcgammaRIII were required for ADCC with hu14.18 alone or mixed with GM-CSF, but that only FcgammaRII was required for ADCC with hu14.18/GM-CSF. ADCC mediated by hu14.18 and hu14.18/GM-CSF was Mac-1 dependent. Electron microscopy demonstrated the greatest PMN adhesion, spreading, and lysis of targets with hu14.18/GM-CSF. Monoclonal antibodies blocking Mac-1 function allowed the tethering of PMN to targets with hu14.18/GM-CSF but prevented adhesion, spreading, and cytolysis. Flow cytometry showed that hu14.18 with or without GM-CSF and hu14.18/GM-CSF all mediated Mac-1-dependent PMN-target cell conjugate formation but that GM-CSF was required for the highest expression and activation of Mac-1, as evidenced by the mAb24-defined beta(2)-integrin activation epitope. Hu14.18/GM-CSF induced the highest sustained azurophil granule exocytosis, almost exclusively in PMNs with activated Mac-1. Thus, hu14.18/GM-CSF facilitates PMN ADCC against neuroblastoma cells associated with FcgammaRII and Mac-1-dependent enhanced adhesion and degranulation.

摘要

多形核白细胞(PMNs)介导抗体依赖性细胞毒性(ADCC),添加粒细胞-巨噬细胞集落刺激因子(GM-CSF)可增强这种毒性。我们试图确定添加抗体/GM-CSF融合蛋白是否也会增强PMN ADCC,以及这是否与Mac-1(CD11b/CD18)的上调和激活以及嗜天青颗粒胞吐作用有关。采用4小时的羧基荧光素乙酰氧基甲酯(calcein-AM)微细胞毒性试验、电子显微镜和多参数流式细胞术评估针对LA-N-1人神经母细胞瘤细胞的ADCC。在calcein-AM试验中,当PMN ADCC由抗二唾液酸神经节苷脂(抗-GD2)免疫细胞因子hu14.18/GM-CSF、与GM-CSF混合的单克隆抗体(mAb)hu14.18以及单独的hu14.18介导时,LA-N-1细胞存活率分别为10%、55%和75%。功能阻断单克隆抗体表明,单独使用hu14.18或与GM-CSF混合进行ADCC时需要FcγRII和FcγRIII,但使用hu14.18/GM-CSF进行ADCC时仅需要FcγRII。由hu14.18和hu14.18/GM-CSF介导的ADCC依赖于Mac-1。电子显微镜显示,hu14.18/GM-CSF导致的PMN对靶标的黏附、铺展和裂解作用最强。阻断Mac-1功能的单克隆抗体允许PMN与hu14.18/GM-CSF结合至靶标,但阻止黏附、铺展和细胞溶解。流式细胞术显示,无论有无GM-CSF的hu14.18以及hu14.18/GM-CSF均介导依赖于Mac-1的PMN-靶细胞共轭体形成,但GM-CSF是Mac-1最高表达和激活所必需的,这由mAb24定义的β2整合素激活表位所证实。Hu14.18/GM-CSF诱导最高水平的持续嗜天青颗粒胞吐作用,几乎仅在具有激活的Mac-1的PMN中出现。因此,hu14.18/GM-CSF促进PMN对神经母细胞瘤细胞的ADCC,这与FcγRII和依赖于Mac-1的增强黏附和脱颗粒作用相关。

相似文献

1
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.抗唾液酸神经节苷脂/粒细胞巨噬细胞集落刺激因子融合蛋白促进中性粒细胞抗体依赖性细胞毒性作用,并且增强效应细胞黏附及嗜天青颗粒胞吐作用依赖于FcγRII(CD32)和Mac-1(CD11b/CD18)。
Blood. 2002 Jun 1;99(11):4166-73. doi: 10.1182/blood.v99.11.4166.
2
Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins.暴露于粒细胞-巨噬细胞集落刺激因子的中性粒细胞介导的单克隆Lym-1抗体依赖性细胞溶解:FcγRII(CD32)、CD11b-CD18整合素和CD66b糖蛋白的干预作用
Blood. 1999 May 15;93(10):3505-11.
3
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.粒细胞集落刺激因子(G-CSF)作为 GM-CSF 的替代选择,可增强神经母细胞瘤治疗中迪诺单抗介导的中性粒细胞细胞毒性。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002259.
4
Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.中性粒细胞对于带有抗GD2抗体的神经母细胞瘤细胞具有细胞毒性并能抑制其生长,但在无细胞毒性时则可刺激其生长。
Cancer Immunol Immunother. 2000 Feb;48(11):603-12. doi: 10.1007/s002620050008.
5
Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity.单克隆抗体介导的中性粒细胞抗人肿瘤细胞毒性对CD11/CD18黏附分子、FcRII及磷脂酰肌醇连接的FcRIII的绝对需求。
Blood. 1992 Mar 15;79(6):1484-90.
6
Monoclonal Lym-1 antibody-targeted lysis of B lymphoma cells by neutrophils. Evidence for two mechanisms of FcgammaRII-dependent cytolysis.中性粒细胞对B淋巴瘤细胞的单克隆Lym-1抗体靶向裂解。FcγRII依赖性细胞溶解两种机制的证据。
J Leukoc Biol. 2000 Nov;68(5):662-8.
7
Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies.在多种单克隆抗体存在的情况下,粒细胞集落刺激因子、粒细胞/巨噬细胞集落刺激因子和巨噬细胞集落刺激因子激活的白细胞对肿瘤细胞的细胞毒性。
Cancer Immunol Immunother. 1994 Oct;39(4):254-62. doi: 10.1007/BF01525989.
8
Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.集落刺激因子增强髓样效应细胞对神经外胚层肿瘤细胞的细胞毒性。
Br J Haematol. 1993 Apr;83(4):545-53. doi: 10.1111/j.1365-2141.1993.tb04689.x.
9
The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.Ch14.18-GM-CSF融合蛋白在体外介导抗体依赖性细胞毒性和补体依赖性细胞毒性方面有效。
Clin Cancer Res. 1999 Dec;5(12):4259-63.
10
Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子增强抗GD2单克隆抗体220-51对人神经母细胞瘤的体内外抗肿瘤活性
Int J Mol Med. 1998 Oct;2(4):471-5. doi: 10.3892/ijmm.2.4.471.

引用本文的文献

1
Antibody-Dependent Cellular Cytotoxicity of iPS Cell-Derived Natural Killer T Cells by Anti-GD2 mAb for Neuroblastoma.抗GD2单克隆抗体介导的诱导多能干细胞衍生的自然杀伤T细胞对神经母细胞瘤的抗体依赖性细胞毒性作用
Cancer Sci. 2025 Apr;116(4):884-896. doi: 10.1111/cas.70008. Epub 2025 Feb 6.
2
Implications of glycosylation for the development of selected cytokines and their derivatives for medical use.糖基化对选定细胞因子及其衍生物在医学用途方面的发展的影响。
Biotechnol Adv. 2024 Dec;77:108467. doi: 10.1016/j.biotechadv.2024.108467. Epub 2024 Oct 22.
3
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies.
中性粒细胞在肿瘤微环境中的复杂作用:新型免疫疗法的途径。
Cancer Biol Med. 2024 Sep 19;21(10):849-63. doi: 10.20892/j.issn.2095-3941.2024.0192.
4
Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade.阻断 CD47 可增强 IgA 介导的中性粒细胞对神经母细胞瘤的细胞毒性。
J Immunother Cancer. 2024 May 23;12(5):e008478. doi: 10.1136/jitc-2023-008478.
5
GD2-targeting therapy: a comparative analysis of approaches and promising directions.靶向 GD2 的治疗方法:方法比较分析及有前景的方向。
Front Immunol. 2024 Mar 15;15:1371345. doi: 10.3389/fimmu.2024.1371345. eCollection 2024.
6
Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment.处于十字路口的中性粒细胞:解析其在肿瘤微环境中的多面作用
Int J Mol Sci. 2024 Mar 2;25(5):2929. doi: 10.3390/ijms25052929.
7
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma.对于高危神经母细胞瘤,采用GM-CSF、G-CSF或不进行细胞因子治疗联合抗GD2免疫疗法。
Int J Cancer. 2024 Apr 15;154(8):1340-1364. doi: 10.1002/ijc.34815. Epub 2023 Dec 18.
8
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.粒细胞集落刺激因子(G-CSF)作为 GM-CSF 的替代选择,可增强神经母细胞瘤治疗中迪诺单抗介导的中性粒细胞细胞毒性。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002259.
9
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.神经母细胞瘤细胞对抗二唾液酸神经节苷脂抗体的内化作为免疫治疗抵抗的机制。
Cancer Immunol Immunother. 2022 Jan;71(1):153-164. doi: 10.1007/s00262-021-02963-y. Epub 2021 May 27.
10
Utilizing Immunocytokines for Cancer Therapy.利用免疫细胞因子进行癌症治疗。
Antibodies (Basel). 2021 Mar 9;10(1):10. doi: 10.3390/antib10010010.